Ondansetron B. Braun 0.08/0.16 mg/ml solution for infusion
Antiemetic for intravenous infusion
Product Description:
Adults
- Prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy (CINV/RINV)
- Prevention and treatment of post-operative nausea and vomiting (PONV).
Paediatric population
- Management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥ 6 months
- Prevention and treatment of postoperative nausea and vomiting (PONV) in children aged ≥ 1 month.
Available in:
- Ondansetron 0.08 mg/ml: Ecoflac® plus 100 ml
- Ondansetron 0.16 mg/ml: Ecoflac® plus 50 ml
Advantages:
- MHRA advice for healthcare professionals to dilute Ondansetron and infuse over at least 15 minutes for patients age 65 years or older.
- Ready-to-use dose product eliminates intermediate steps and helps to prevent dosage errors.